Skip to main
Kisspeptin Chemical A research digest on Kisspeptin — the KISS1-gene neuropeptide that sits at the very top of the reproductive axis, read from the published literature, discovery first.

The masthead

About Kisspeptin Chemical

A sourced, plain reading of the published Kisspeptin literature — discovery-first, and cited throughout.

What this site is

Kisspeptin Chemical reads the peer-reviewed research literature on Kisspeptin and summarizes it in plain, cited prose. There is no clinic behind it, no clinical staff, and no medical advice; it summarizes published science and treats no one. It manufactures, sells, and distributes nothing.

The "chemical" in the name is editorial framing — a position this publisher occupies relative to the literature, reading kisspeptin as a research compound traced from gene to hormone. It is not a claim that the site offers any chemical, product, consultation, or service.

How we read the literature

This digest takes a discovery-first view: kisspeptin's story runs from a 1996 cancer-suppressor gene, through the deorphanization of GPR54, to the 2003 finding that recast it as the master switch of the reproductive axis. We lead with what each study measured and attribute it to its source. Doses appear only as what was administered to a stated population by a stated route — never as guidance. Every quantitative claim is cited to a PubMed-indexed study on the references page.

How we read the literature

What we are careful about

Kisspeptin is investigational: no regulator has approved any kisspeptin product for any indication, and it is not a dietary supplement. We say so on every page. We keep kisspeptin in its correct place — upstream of GnRH, not itself a sex hormone or a GnRH-agonist drug — and we flag its defining limitation, tachyphylaxis, wherever dosing schedule or efficacy is discussed. Subjective community reports about sexual desire, fertility, or testosterone are kept clearly separate from cited findings and labeled as anecdotal, not clinical evidence. We use generic compound names only.

Who writes this

Kisspeptin Chemical is an editorial publication, not a person or a practice. It carries no named clinician, no physical clinic, and no consultation service. It exists to make a dense, technical literature readable and verifiable for curious readers — to summarize the science accurately, cite it, and leave the practice of medicine to physicians.